Previous 10 | Next 10 |
MOUNTAIN VIEW, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Ken Ludlum has been appointed to its Board of Directors, eff...
MOUNTAIN VIEW, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that its Cyclo G6® Glaucoma Laser and proprietary MicroPulse...
MOUNTAIN VIEW, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming Spring Investor Summit in New York, NY. Chairman and CEO William Moore is scheduled to present on Monday, April 1, 2019 at 3:00 PM ET.&...
MOUNTAIN VIEW, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming 31 st Annual Roth Conference in Orange County, CA. Management is scheduled to present on Tuesday, March 19, 2019 at 9:00 AM PT. ...
IRIDEX Corporation (IRIX) Q4 2018 Earnings Conference Call March 5, 2019 05:00 pm ET Company Participants Leigh Salvo - Head of Investor Relations Will Moore - President and Chief Executive Officer Romeo Dizon - Vice President and Controller Conference Call Participants Joh...
IRIDEX (NASDAQ: IRIX ) Q4 results ($M): Revenue: 11.5 (+12.7%). More news on: IRIDEX Corporation, Healthcare stocks news, Earnings news and commentary, , Read more ...
IRIDEX (NASDAQ: IRIX ): Q4 GAAP EPS of -$0.21 misses by $0.02 . More news on: IRIDEX Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
MOUNTAIN VIEW, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended December 29, 2018. Fourth Quarter Highlights Cyclo G6 ® product revenue increased approximately 16% year-over-yea...
MOUNTAIN VIEW, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year 2018 after the close of trading on Tuesday, March 5, 2019. The Company’s management team wi...
IRIDEX (NASDAQ: IRIX ) has resolved its differences with Quantel in its lawsuit filed against the latter in the U.S. District Court for the Northern District of California. More news on: IRIDEX Corporation, Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company...